HK1115324A1 - Therapeutic agent for disease with apoptotic degeneration in eye tissue cell containing pedf and fgf2 - Google Patents

Therapeutic agent for disease with apoptotic degeneration in eye tissue cell containing pedf and fgf2

Info

Publication number
HK1115324A1
HK1115324A1 HK08111109.7A HK08111109A HK1115324A1 HK 1115324 A1 HK1115324 A1 HK 1115324A1 HK 08111109 A HK08111109 A HK 08111109A HK 1115324 A1 HK1115324 A1 HK 1115324A1
Authority
HK
Hong Kong
Prior art keywords
fgf2
disease
therapeutic agent
cell containing
eye tissue
Prior art date
Application number
HK08111109.7A
Other languages
English (en)
Original Assignee
Dnavec Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dnavec Corp filed Critical Dnavec Corp
Publication of HK1115324A1 publication Critical patent/HK1115324A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
HK08111109.7A 2005-02-23 2008-10-08 Therapeutic agent for disease with apoptotic degeneration in eye tissue cell containing pedf and fgf2 HK1115324A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005048064 2005-02-23
PCT/JP2006/303052 WO2006090697A1 (ja) 2005-02-23 2006-02-21 Pedfおよびfgf2を含む眼組織細胞におけるアポトーシス変性を伴う疾患の治療薬

Publications (1)

Publication Number Publication Date
HK1115324A1 true HK1115324A1 (en) 2008-11-28

Family

ID=36927337

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08111109.7A HK1115324A1 (en) 2005-02-23 2008-10-08 Therapeutic agent for disease with apoptotic degeneration in eye tissue cell containing pedf and fgf2

Country Status (4)

Country Link
JP (1) JP4971974B2 (xx)
CN (1) CN101160139B (xx)
HK (1) HK1115324A1 (xx)
WO (1) WO2006090697A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012126369A1 (zh) * 2011-03-22 2012-09-27 北京三诺佳邑生物技术有限责任公司 核苷酸、包括其的重组载体、细胞、组合物及它们的应用
CN103060378A (zh) * 2011-10-24 2013-04-24 四川百利药业有限责任公司 一种siv载体的制备方法
CN103316356B (zh) 2012-03-22 2016-08-17 北京三诺佳邑生物技术有限责任公司 一种重组慢病毒载体制剂
CN102788883B (zh) * 2012-08-30 2014-11-05 重庆医科大学 一种用于检测抑郁症的试剂盒
WO2015053398A1 (ja) * 2013-10-11 2015-04-16 タカラバイオ株式会社 高力価レトロウイルスベクター

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1403374A4 (en) * 2001-06-08 2004-07-21 Dnavec Research Inc GENE TRANSFER IN EMBRYONIC PRIMATE STEM CELLS WITH THE VSV-G PSEUDOTYPE MONKEY IMMUNITY WEAK VIRUS VECTOR

Also Published As

Publication number Publication date
CN101160139B (zh) 2011-10-12
JP4971974B2 (ja) 2012-07-11
JPWO2006090697A1 (ja) 2008-07-24
CN101160139A (zh) 2008-04-09
WO2006090697A1 (ja) 2006-08-31

Similar Documents

Publication Publication Date Title
GB0523576D0 (en) Drug composition and its use in therapy
ZA200800434B (en) Benzoquinazoline derivatives and their use in treating bone disorders
FI3524261T3 (fi) Exendin käytettäväksi diabeteksen hoidossa ja ruumiin painon vähentämiseksi
GB2437875B (en) Skin care composition comprising L-carnosine and N-acetylcysteine
EP1895946A4 (en) IMPROVEMENTS FROM AND RELATED TO SURGICAL IMPLANTS
EP1868656A4 (en) BIOACTIVE STENTS FOR TYPE II DIABETICS AND METHODS FOR USING SAME
EP1766768A4 (en) USE OF LACRITINE AS A PROMOTER OF EYE CELL OVER LIFE
PL2359701T3 (pl) Kompozycja poprawiająca skład błony i funkcjonowanie komórek do stosowania w leczeniu alergii
EP2155235A4 (en) OXYGEN GENERATING COMPOSITIONS FOR INCREASING THE SURVIVAL OF IN VIVO CELLS AND TISSUES
EP1908011A4 (en) RECONSTRUCTION STABILIZER AND ACTIVE VISION
EP1737379A4 (en) BIOACTIVE VASCULAR STENTS FOR DIABETES TYPE II AND METHODS OF USE
EP1868430A4 (en) COMPOSITION AND METHOD FOR IN VITRO PRESERVATION OF CORNEH TISSUE
EP1884234A4 (en) PROPHYLACTIC OR THERAPEUTIC AGENT FOR DISEASES OF CORNEAL AND BINDING SKIN
IL192206A0 (en) Topical mecamylamine formulations for ocular administration and uses thereof
HK1115324A1 (en) Therapeutic agent for disease with apoptotic degeneration in eye tissue cell containing pedf and fgf2
HK1112848A1 (en) Pharmaceutical composition for regenerating myofibers in the treatment of muscle injuries
GB2431356B (en) Improvements in and relating to disposable dispensers for personal use
IL186634A0 (en) Compositions facilitating drug penetration and drug retention in skin
IL201426A0 (en) Drug combination and its use in the treatment of muscle loss
IL185586A0 (en) 1,2,4-triazine derivatives, preparation and use thereof in human therapy
EP2034829A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING CYCLOBENZAPRIN AND ACECLOFENAC IN ASSOCIATION
GB0523166D0 (en) Improvements in and relating to medical products
GB0523578D0 (en) Drug composition and its use in therapy
GB0523577D0 (en) Drug composition and its use in therapy
GB0511329D0 (en) Improvements in and relating to surgical implants

Legal Events

Date Code Title Description
CORR Corrigendum

Free format text: CORRECTED DATA OF SECTION 20 TO JOURNAL OF 20081128: (72)

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160221